Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01976273 · ClinicalTrials.gov registry record · NA
A Pilot Study Testing 1064nm Q-switch Laser Versus Glycolic Acid Peels for the Treatment of Melasma
A NA study of Melanosis, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01976273 is a NA study of Melanosis that has completed, run by Northwestern University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01976273, a NA study of Melanosis, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out the safety and effectiveness of 1064 Q-Switch Laser Therapy compared to Glycolic Acid Chemical Peels for the treatment of melasma.
Conditions Studied
Interventions
- OTHER Glycolic Acid Peels
- DEVICE 1064nm Q-switch Laser
Study Locations (1)
Illinois
- Northwestern University Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-01-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01976273
The ClinicalTrials.gov registry entry for NCT01976273 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Melanosis appearing as the primary indexed condition, and to 2 interventions - of which Glycolic Acid Peels is the first listed.
NCT01976273 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01976273 about?
NCT01976273 is a clinical study titled "A Pilot Study Testing 1064nm Q-switch Laser Versus Glycolic Acid Peels for the Treatment of Melasma". The purpose of this study is to find out the safety and effectiveness of 1064 Q-Switch Laser Therapy compared to Glycolic Acid Chemical Peels for the treatment of melasma.
What is the current status of trial NCT01976273?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-10. Estimated completion is 2015-01-07.
What conditions does trial NCT01976273 study?
This clinical trial studies the following conditions: Melanosis.
What interventions are being tested in trial NCT01976273?
The interventions under investigation include: Glycolic Acid Peels (OTHER), 1064nm Q-switch Laser (DEVICE).
Who is sponsoring clinical trial NCT01976273?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01976273 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.